ABEONA THERAPEUTICS INC. Repayments of Long-Term Debt
ABEONA THERAPEUTICS INC. (ABEO) reported Repayments of Long-Term Debt of $5.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. repayments of long-term debt for the quarter ending 2026-06-30 was $3.33M.
- ABEONA THERAPEUTICS INC. repayments of long-term debt for the quarter ending 2026-03-31 was $2.22M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month |
|---|---|---|
| 2026-06-30 | $3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $5.56M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.22M 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |